Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's stock, including the acquisition of phantom units and adjustments to holdings of employee stock options and restricted stock units.
Summary
- On February 18, 2025, John J. Corkrean, Executive VP and CFO of H.B. Fuller, reported changes in his beneficial ownership of the company's securities.
- The report details the acquisition of 152.59 phantom units on February 14, 2025, which convert into common stock on a 1-for-1 basis.
- Corkrean's holdings include 52,196 shares of common stock.
- He also holds various employee stock options with exercise prices ranging from $43.48 to $77.72 and expiration dates between 2026 and 2035.
- These options represent the right to buy a total of 263,004 shares of common stock.
- Corkrean also possesses restricted stock units that convert into common stock on a 1-for-1 basis, with vesting schedules over three years.
- The report includes adjustments to holdings due to dividend equivalent features and reinvestments.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing. The sentiment is neutral as it simply reports changes in ownership.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders and their holdings in the company. It allows investors to track the actions of key personnel.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the holdings and transactions of a key executive.
- It can influence investor sentiment depending on the nature and volume of the transactions.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of employee stock option grant with an exercise price of $43.48, expiring on 05/17/2026. |
| 01/26/2018 | Date of employee stock option grant with an exercise price of $50.1, expiring on 01/26/2027. |
| 01/25/2019 | Date of employee stock option grant with an exercise price of $53.57, expiring on 01/25/2028. |
| 01/24/2020 | Date of employee stock option grant with an exercise price of $45.05, expiring on 01/24/2029. |
| 01/24/2021 | Date of employee stock option grant with an exercise price of $48.35, expiring on 01/24/2030. |
| 01/27/2022 | Date of employee stock option grant with an exercise price of $51.89, expiring on 01/27/2031. |
| 01/24/2023 | Date of employee stock option grant with an exercise price of $72.94, expiring on 01/24/2032. |
| 01/24/2024 | Date of employee stock option grant with an exercise price of $68.17, expiring on 01/24/2033, and restricted stock units vesting in three annual installments beginning on this date and expiring on 01/24/2026. |
| 01/26/2025 | Date of employee stock option grant with an exercise price of $77.72, expiring on 01/26/2034, and restricted stock units vesting in three annual installments beginning on this date and expiring on 01/26/2027. |
| 01/27/2026 | Date of employee stock option grant with an exercise price of $64.28, expiring on 01/27/2035, and restricted stock units vesting in three annual installments beginning on this date and expiring on 01/27/2028. |
| 02/14/2025 | Date of transaction involving the acquisition of phantom units. |
| 02/18/2025 | Date of the Form 4 filing. |
Keywords
beneficial ownership, Form 4, H.B. Fuller, stock options, restricted stock units, phantom units, insider trading, securities, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.